331 related articles for article (PubMed ID: 10230180)
1. Methylphenidate versus dextroamphetamine in ADHD.
Efron D
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):500. PubMed ID: 10230180
[No Abstract] [Full Text] [Related]
2. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
't Jong GW; van den Anker JN
Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
[No Abstract] [Full Text] [Related]
3. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
4. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.
Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492
[TBL] [Abstract][Full Text] [Related]
5. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
6. Stimulant therapy in attention deficit/hyperactivity disorder.
Baldwin RL
J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
[TBL] [Abstract][Full Text] [Related]
8. A one year trial of methylphenidate in the treatment of ADHD.
Wender PH; Reimherr FW; Marchant BK; Sanford ME; Czajkowski LA; Tomb DA
J Atten Disord; 2011 Jan; 15(1):36-45. PubMed ID: 20071637
[TBL] [Abstract][Full Text] [Related]
9. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
[TBL] [Abstract][Full Text] [Related]
10. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
11. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
Varley CK
Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
[No Abstract] [Full Text] [Related]
12. [Stimulant therapy in children].
Steinhausen HC
Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
[No Abstract] [Full Text] [Related]
13. [Methylphenidate double-blind trial: indication and performing].
Bliznakova L; Gerstner S; Schmidt MH; Becker K
Klin Padiatr; 2007; 219(1):9-16. PubMed ID: 17205427
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
15. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
Airaksinen E; Airaksinen MM
Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
[No Abstract] [Full Text] [Related]
16. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
17. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.
Pliszka SR; Browne RG; Olvera RL; Wynne SK
J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):619-26. PubMed ID: 10802980
[TBL] [Abstract][Full Text] [Related]
19. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
[TBL] [Abstract][Full Text] [Related]
20. Treatment of attention-deficit-hyperactivity disorder.
Elia J; Ambrosini PJ; Rapoport JL
N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
